• search

Kapil Sibal calls for focus on developing low cost drugs

Written by: Staff

Bangalore, June 7 (UNI) Union Minister for Science and Technology Kapil Sibal today urged the stakeholders in the Biotech sector to focus on developing drugs cost of which were affordable to commonman.

Speaking after inaugurating the Bangalore Bio-2006, the country's largest Biotech show here, he said, ''it is hightime that investors should invest, keeping in mind the urgent need to find drugs for serious diseases, and at the same time it should be made available at affordable price to commonman.

Mr Sibal said public funding on inventing new drugs which have become burden on the poor people should be enhanced and expressed concern that it is very much low as compared to western countries.

The multinational companies are finding it very difficult to peg down the cost of manufacturing drugs, and looking towards India which has a large pool of talent and low cost economy.

Acknowledging that the Biotechnology was a heavy capital intensive, Mr Sibal urged the Union Government to help the private industry engaged in developing new moleclues and drugs by joining hands with them, to produce low cost drugs and drug delivery system.

Referring to the statistics that in India only one per cent of the total sales of the BT industry was being put to Research and Development, the Minister said that it is a very negligble amount and urged it should be enhanced and opined that the Government of India has a major responsiblity to mitigate the problem.


For Daily Alerts
Get Instant News Updates
Notification Settings X
Time Settings
Clear Notification X
Do you want to clear all the notifications from your inbox?
Settings X
We use cookies to ensure that we give you the best experience on our website. This includes cookies from third party social media websites and ad networks. Such third party cookies may track your use on Oneindia sites for better rendering. Our partners use cookies to ensure we show you advertising that is relevant to you. If you continue without changing your settings, we'll assume that you are happy to receive all cookies on Oneindia website. However, you can change your cookie settings at any time. Learn more